Zacks Investment ResearchTue, 12 May 2026 13:41:07 GMTXilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue EstimatesXLO+1.24%
Zacks Investment ResearchWed, 01 Apr 2026 17:01:10 GMTXilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock?XLO+1.24%